The India Helicobacter Pylori Test Market is segmented according to test type, technology, and end user. Market Research Future reports that the industry was valued at USD 161.72 million in 2024 and is expected to reach USD 250 million by 2035, expanding at a CAGR of 4.04% from 2025 to 2035.

By test type, the market is divided into non-endoscopic and endoscopic testing. Non-endoscopic testing currently represents the larger segment due to its convenient and less invasive characteristics. Endoscopic testing, however, is gaining importance because of improvements in gastrointestinal diagnostic technologies.

Based on technology, the market includes immunoassays, point-of-care testing, and molecular diagnostics. Immunoassays maintain a strong position because they are established diagnostic techniques used across healthcare settings. Molecular diagnostics represent an emerging opportunity because of growing demand for highly accurate and specific diagnostic solutions.

Hospitals and clinics account for a major share of end-user demand, supported by established healthcare infrastructure and high patient volumes. Diagnostic laboratories are also becoming increasingly important as demand for specialized testing services grows.

Major companies associated with the broader market include Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Meridian Bioscience, and Eiken Chemical.

Competition is increasingly influenced by technological innovation, product reliability, accessibility, and the development of rapid diagnostic solutions.

Strengthen your strategy with data-backed research insights:

Intrauterine Contraceptive Devices (IUCDs) Market Outlook

Perfusion Radiology Market Analysis

Surgical Tubing Market Distribution

Diabetic Ulcer Treatment Market Size

Medical Image Management Market Share